| 1 |
Frederick Arthur Brookfield |
Cardioxyl Pharmaceuticals |
8 |
| 1 |
Pierre-Henri Storck |
Vertex Pharmaceuticals Incorporated |
8 |
| 3 |
Stephen Martin Courtney |
Cardioxyl Pharmaceuticals |
7 |
| #4 |
Ronald Knegtel |
Vertex Pharmaceuticals Incorporated |
6 |
| #4 |
Lisa Marie Frost |
Cardioxyl Pharmaceuticals |
6 |
| #6 |
Gorka Etxebarria I Jardi |
Vertex Pharmaceuticals Incorporated |
4 |
| #6 |
Francoise Pierard |
Vertex Pharmaceuticals Incorporated |
4 |
| #6 |
Andrew Humphris |
Infinitesima Limited |
4 |
| #6 |
Damien Fraysse |
Vertex Pharmaceuticals Incorporated |
4 |
| #10 |
Nicholas Salvatore Arini |
Google |
3 |
| #10 |
David Festus Charles Moffat |
Chroma Therapeutics |
3 |
| #12 |
Simon Tonks |
Abbott |
2 |
| #12 |
Alan Hornsby Davidson |
British Biotechnology |
2 |
| #12 |
Stuart Flanagan |
Ono Pharmaceutical Co. |
2 |
| #12 |
Michael Prime |
Chdi Foundation |
2 |
| #12 |
Chris Yarnold |
Ono Pharmaceutical Co. |
2 |
| #12 |
Steve Courtney |
Ono Pharmaceutical Co. |
2 |
| #12 |
Juan-Miguel Jimenez |
Vertex Pharmaceuticals Incorporated |
2 |
| #12 |
Paul Beasley |
Siemens Aktiengesellschaft |
2 |
| #12 |
Laura Richard |
Velocys Technologies |
2 |
| #12 |
Carl Leslie North |
Padlock Therapeutics |
2 |
| #12 |
Sivanendra Selvanayagam |
— |
2 |
| #12 |
Graham Michael Wynne |
Oxagen Limited |
2 |
| #12 |
Richard Heap |
Faradion Limited |
2 |
| #12 |
Giles W. Theaker |
Infineum International Limited |
2 |
| #26 |
Nick Cooper |
Viavi Solutions Uk Limited |
1 |
| #26 |
Mark Eddleston |
Cephalon |
1 |
| #26 |
Thomas Martin Krulle |
Prosidion Limited |
1 |
| #26 |
Peter Randall |
Viavi Solutions Uk Limited |
1 |
| #26 |
Phillip Barclay |
— |
1 |
| #26 |
Kamel Madi |
Corning Incorporated |
1 |
| #26 |
Amanda Harding |
Green Biologics Limited |
1 |
| #26 |
Alan Geoffrey Roach |
Rhone-Poulenc Rorer Limited |
1 |
| #26 |
Ashley Jarvis |
Ark Therapeutics |
1 |
| #26 |
Naomi Went |
Chdi Foundation |
1 |
| #26 |
Francis Xavier Wilson |
Hoffmann-La Roche |
1 |
| #26 |
James Ritchie |
Topotarget Uk Limited |
1 |
| #26 |
Mark Wakefield |
Schlumberger Technology |
1 |
| #26 |
Gregory Foulkes |
Ucb Biopharma Srl |
1 |
| #26 |
Julian M. C. Golec |
Vertex Pharmaceuticals Incorporated |
1 |
| #26 |
Alistair Rutherford |
Vertex Pharmaceuticals Incorporated |
1 |
| #26 |
Stephen Coulson |
P2I |
1 |
| #26 |
Petra Dieterich |
American Cyanamid |
1 |
| #26 |
Victor Alexandrovich Kalinin |
Transense Technologies, Plc |
1 |
| #26 |
Francesca Ann Day |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #26 |
Marcello Alecci |
Btg International |
1 |
| #26 |
Richard John Vickers |
Summit Corporation Plc |
1 |
| #26 |
Olivier De Moor |
Summit Corporation Plc |
1 |
| #26 |
Gareth Neil Brace |
Ucb Biopharma Srl |
1 |
| #26 |
Alan Bond |
Reaction Engines |
1 |